Redesign Health, a healthcare venture builder, has announced the closing of a $175 million fund to support healthcare company creation. The new fund includes investment from Declaration Partners, Euclidean Capital, and True North Advisors.
“Healthcare founders today benefit from unprecedented tailwinds. AI, aligned payment models, patient demand for better care, and unsustainable cost pressures set the stage for generational value creation and social impact,” said Brett Shaheen, Founder and CEO of Redesign Health. “At the same time, building healthcare companies is really hard. Founders encounter opaque value chains, complex regulations, long sales cycles, and almost no tolerance for error. We built Redesign to help founders overcome these challenges and capture a historic opportunity to accelerate innovation in service of patients.”
Since its founding in 2018, Redesign Health has supported the launch of more than 60 companies that have reached over 15 million patients and generated more than $1 billion in revenue. The company’s venture-building model provides founders with support across ideation and diligence, commercial traction, and execution.
The company focuses on eight key areas for innovation: addressing healthcare labor shortages, accelerating value-based care, advancing healthcare interoperability, preparing for an aging population, eliminating barriers to health equity, expanding sites of care, growing the insured population, and driving healthcare personalization and consumerization.
The new funding will support the launch of dozens of companies over the next few years, leveraging recent advances in AI, data integration, and software development to transform care delivery.
